Cancer Resource Center - 医疗专业人员

Cancer

专题新闻

Dec. 15, 2022

Addressing the rising incidence of early-onset colorectal cancer

Mayo Clinic gastroenterologist Frank A. Sinicrope, M.D., analyzes current evidence related to the phenotype and diagnosis of early-onset colorectal cancer and strategies to address the increasing incidence of this disease.

Nov. 30, 2022

Kidney-sparing therapy for low-grade upper tract urothelial cancer

In a multicenter phase 3 study, researchers identified a kidney-sparing therapy for patients with a rare urologic cancer. Mayo Clinic experts enhanced the mitomycin-containing reverse thermal gel for safety and fewer adverse events.

Aug. 12, 2022

AI-assisted colonoscopies reduce miss rate by 50 percent

In a multicenter, multicountry study, Mayo Clinic Gastroenterology and Hepatology joined a global collaboration to analyze the use of artificial intelligence (AI) in colorectal cancer screening. AI support reduced adenoma miss rate twofold.

Dec. 15, 2022

Colorectal cancer screening tailored to each patient's needs

With the advent of less invasive colorectal cancer screening options, more care teams are tailoring screening to each patient's needs. The best screening is the one with which a patient will follow through.

Optimizing outcomes for patients with nonmetastatic pancreatic cancer

Mark J. Truty, M.D., and colleagues discuss new research improving outcomes in pancreatic cancer. The team shares updates on staging exams, optimal response assessment and novel surgical procedures for traditionally inoperable patients.

GI Neoplasia Clinic

There are many new and established ways to test and treat patients with gastrointestinal neoplasia at Mayo Clinic.

Liver cancer innovations and advanced treatment options

Liver cancer specialists at Mayo Clinic Comprehensive Cancer Center offer hope to patients in the form of the highest quality therapies available. At the Cancer Center, patients with liver cancer may have access to personalized chemotherapy regimens, proton beam and other highly focused radiation therapies and prostate-specific membrane antigen.

医疗专业人员